Deferoxamine promotes osteoblastic differentiation in human periodontal ligament cells via the nuclear factor erythroid 2-related factor-mediated antioxidant signaling pathway.
about
NRF2 Is a Key Target for Prevention of Noise-Induced Hearing Loss by Reducing Oxidative Damage of Cochlea.BGRMI: A method for inferring gene regulatory networks from time-course gene expression data and its application in breast cancer researchWnt5a is a key target for the pro-osteogenic effects of iron chelation on osteoblast progenitors.Stimulating angiogenesis mitigates the unloading-induced reduction in osteogenesis in early-stage bone repair in rats.Desferrioxamine reduces ultrahigh-molecular-weight polyethylene-induced osteolysis by restraining inflammatory osteoclastogenesis via heme oxygenase-1.Cellular localization of NRF2 determines the self-renewal and osteogenic differentiation potential of human MSCs via the P53-SIRT1 axis.Effects of Antioxidant Supplements on the Survival and Differentiation of Stem Cells.Static magnetic fields promote osteoblastic/cementoblastic differentiation in osteoblasts, cementoblasts, and periodontal ligament cells.Dimethyl fumarate inhibits osteoclasts via attenuation of reactive oxygen species signalling by augmented antioxidation.Expression of Caveolin-1 in Periodontal Tissue and Its Role in Osteoblastic and Cementoblastic Differentiation In Vitro.Deferoxamine released from poly(lactic-co-glycolic acid) promotes healing of osteoporotic bone defect via enhanced angiogenesis and osteogenesis.Role of PIN1 on in vivo periodontal tissue and in vitro cells.
P2860
Q27301747-352B8F9D-9699-417C-941C-9A79BF5408EDQ28595423-8FD0C1C2-67B7-481A-8410-51DD48C2CA01Q33822010-E0A08749-1125-40EB-988D-1A958D43D678Q35363264-EF7506B8-F900-495A-B4D6-45DE83D26CF9Q37465978-99D7CCAE-16F1-4EAD-AA19-2A5ABD79A5ECQ40757164-538BA5DE-AE32-4AE2-9EED-92A349ECEBB0Q41099472-6BC160EC-E1AB-4E29-97D2-00F156ADE863Q45349682-6932DA36-DD4D-4ECC-8935-E6808D11CDDAQ46276290-74D66F6E-E97D-4E31-B26B-8EC91C9BC935Q50433985-2FFDBC08-9C4D-4801-8ACD-365256ECA467Q51316637-58C7AE68-340E-4EB9-91E2-63CA657634FEQ53121358-EC2E608D-6C68-4698-BE96-D29A0F9AECD0
P2860
Deferoxamine promotes osteoblastic differentiation in human periodontal ligament cells via the nuclear factor erythroid 2-related factor-mediated antioxidant signaling pathway.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Deferoxamine promotes osteobla ...... antioxidant signaling pathway.
@en
Deferoxamine promotes osteobla ...... antioxidant signaling pathway.
@nl
type
label
Deferoxamine promotes osteobla ...... antioxidant signaling pathway.
@en
Deferoxamine promotes osteobla ...... antioxidant signaling pathway.
@nl
prefLabel
Deferoxamine promotes osteobla ...... antioxidant signaling pathway.
@en
Deferoxamine promotes osteobla ...... antioxidant signaling pathway.
@nl
P2093
P2860
P356
P1476
Deferoxamine promotes osteobla ...... antioxidant signaling pathway.
@en
P2093
P2860
P304
P356
10.1111/JRE.12136
P50
P577
2013-10-01T00:00:00Z